Squamous Cell Carcinoma of Esophagus Not Yet Recruiting Phase 2 Trials for Cisplatin (DB00515)

Also known as: Esophageal Squamous Cell Carcinoma (ESCC) / Esophageal Squamous Cell Carcinoma / Esophageal Squamous Cell Carcinomas / Oesophageal squamous cell carcinoma / Esophageal squamous cell carcinoma stage unspecified / Oesophageal epidermoid carcinoma NOS / Esophageal epidermoid carcinoma NOS / Squamous cell carcinoma of oesophagus / Squamous cell carcinoma of esophagus NOS / Oesophageal squamous cell carcinoma NOS / Oesophageal squamous cell carcinoma stage unspecified

IndicationStatusPhase
DBCOND0031573 (Squamous Cell Carcinoma of Esophagus)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04063683Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma(ESCC).Treatment
NCT03857763A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell CarcinomaTreatment